IL137508A0 - Glucocorticoid-selective anti-inflammatory agents - Google Patents

Glucocorticoid-selective anti-inflammatory agents

Info

Publication number
IL137508A0
IL137508A0 IL13750899A IL13750899A IL137508A0 IL 137508 A0 IL137508 A0 IL 137508A0 IL 13750899 A IL13750899 A IL 13750899A IL 13750899 A IL13750899 A IL 13750899A IL 137508 A0 IL137508 A0 IL 137508A0
Authority
IL
Israel
Prior art keywords
glucocorticoid
inflammatory agents
selective anti
mammal
compounds
Prior art date
Application number
IL13750899A
Other languages
English (en)
Original Assignee
Abbott Lab
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Ligand Pharm Inc filed Critical Abbott Lab
Publication of IL137508A0 publication Critical patent/IL137508A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL13750899A 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents IL137508A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (1)

Publication Number Publication Date
IL137508A0 true IL137508A0 (en) 2001-07-24

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13750899A IL137508A0 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Country Status (21)

Country Link
EP (1) EP1053239B1 (ko)
JP (1) JP2002503665A (ko)
KR (1) KR20010040935A (ko)
CN (1) CN1119348C (ko)
AT (1) ATE230749T1 (ko)
AU (1) AU766441B2 (ko)
BG (1) BG64317B1 (ko)
BR (1) BR9907788A (ko)
CA (1) CA2320943A1 (ko)
DE (1) DE69904804T2 (ko)
DK (1) DK1053239T3 (ko)
ES (1) ES2192035T3 (ko)
HK (1) HK1033308A1 (ko)
HU (1) HUP0100460A3 (ko)
IL (1) IL137508A0 (ko)
NO (1) NO20004053L (ko)
NZ (1) NZ506013A (ko)
PL (1) PL193323B1 (ko)
SK (1) SK284689B6 (ko)
TR (1) TR200003094T2 (ko)
WO (1) WO1999041256A1 (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
EP1201660B1 (en) 2000-10-30 2005-08-31 Pfizer Products Inc. Glucocorticoid receptor modulators
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) * 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
WO2003059899A1 (en) 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
RS51097B (sr) 2002-03-26 2010-10-31 Boehringer Ingelheim Pharmaceuticals Inc. Glukokortikoidni mimetici,postupci za njihovo dobijanje, farmaceutski preparati i njihova primena
AU2003230700A1 (en) 2002-03-26 2003-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CA2481320A1 (en) 2002-04-11 2003-10-23 Merck & Co., Inc. 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004018429A2 (en) 2002-08-21 2004-03-04 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
TW200410968A (en) 2002-10-11 2004-07-01 Ligand Pharm Inc 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
WO2004033459A1 (en) * 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO[3,4-f]QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
KR20050109922A (ko) 2003-01-03 2005-11-22 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 1-프로판올과 1-프로필아민 유도체 및 글루코코르티코이드리간드로서의 이들의 용도
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
EP1675839B1 (en) 2003-10-16 2007-07-11 Boehringer Ingelheim Pharmaceuticals Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
DE602005015027D1 (de) 2004-12-27 2009-07-30 Boehringer Ingelheim Pharma Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung
CN102304124B (zh) * 2005-09-14 2014-10-22 参天制药株式会社 具有糖皮质激素受体结合活性的1,2-二氢喹啉衍生物
WO2010147947A2 (en) 2009-06-16 2010-12-23 Schering Corporation NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
CA2769563A1 (en) 2009-07-31 2011-02-10 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ300739A (en) * 1994-12-22 2000-05-26 Ligand Pharm Inc Steroid receptor modulator compounds

Also Published As

Publication number Publication date
BG64317B1 (bg) 2004-09-30
TR200003094T2 (tr) 2001-01-22
HUP0100460A2 (hu) 2001-09-28
KR20010040935A (ko) 2001-05-15
JP2002503665A (ja) 2002-02-05
HUP0100460A3 (en) 2003-03-28
CN1119348C (zh) 2003-08-27
ES2192035T3 (es) 2003-09-16
WO1999041256A1 (en) 1999-08-19
AU2677399A (en) 1999-08-30
NZ506013A (en) 2003-03-28
NO20004053L (no) 2000-09-11
ATE230749T1 (de) 2003-01-15
CA2320943A1 (en) 1999-09-19
SK11972000A3 (sk) 2001-08-06
NO20004053D0 (no) 2000-08-11
SK284689B6 (sk) 2005-09-08
PL343018A1 (en) 2001-07-30
BG104719A (en) 2001-05-31
AU766441B2 (en) 2003-10-16
BR9907788A (pt) 2001-10-30
DK1053239T3 (da) 2003-04-22
HK1033308A1 (en) 2001-08-24
DE69904804T2 (de) 2003-11-06
CN1296486A (zh) 2001-05-23
DE69904804D1 (de) 2003-02-13
PL193323B1 (pl) 2007-02-28
EP1053239A1 (en) 2000-11-22
EP1053239B1 (en) 2003-01-08

Similar Documents

Publication Publication Date Title
HK1033308A1 (en) Glucocorticoid-selective anti-inflammatory agents
BG104698A (en) Glucocorticoid-selective anti-inflammatory agents
WO2002002565A3 (en) Glucocortiocoid-selective antiinflammatory agents
BG105109A (en) Cell adhesion-inhibiting anti-inflammatory compounds
BG105880A (en) Compounds useful as anti-inflammatory agents
EP1034164A4 (en) ALANINE-BETA DERIVATIVES ACTING AS CELL ADHESION INHIBITORS
ATE296283T1 (de) Zelladhäsion- und entzündungshemmende immunosuppressive verbindungen
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
MY133125A (en) Novel dihydroxyhexanoic acid derivatives
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
WO2000006137A3 (en) Glucocorticoid-selective anti-inflammatory agents
ZA979647B (en) Heterocyclic compounds, compositions and uses.
MY128261A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
GB9619660D0 (en) Prevention of gastrointestinal damage
ZA979650B (en) Heterocyclic compounds, compositions and uses.
ZA979645B (en) Heterocyclic compounds, compositions and uses.
AU7150598A (en) Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.